(PharmaNewsWire.Com, January 10, 2017 ) Generic Drugs Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Generic Drugs globally.
The Generic Drugs Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Generic Drugs Market:
Teva Pharmaceuticals Sandoz Allergan Mylan Sun Pharmaceuticals STADA Arzneimittel
Other Prominent Vendors of Generic Drugs Market Are:
Abbott Amgen Apotex Aspen AstraZeneca
“One trend which is influencing market growth is the outsourcing of drug development. Vendors are increasingly using outsourcing as a business strategy as they have been experiencing a decline in venture capital investment. Some vendors outsource parts of their R&D process, such as product characterization testing, and toxicology testing, to contract research organizations. Similarly, some of them outsource parts or even the entirety of their manufacturing processes to other organizations. In this way, outsourcing is becoming a trend in the global generic drugs market.”
According to the Generic Drugs Market report, a key growth driver is the patent expiry of top-selling drugs. With many pharmaceutical drugs set to lose their patents during the forecast period, the competition in the generic market is expected to increase. Patent expiry of a branded drug results in the introduction of inexpensive generic drugs in the market. Branded drugs with sales of up to $135 billion expired by the end of 2015, offering pharmaceutical companies opportunities to capitalize on this market. Moreover, the patent expiry of drugs worth $150 billion by 2020 will fuel the growth of the global generic drugs market.
Report also presents Geographical Segmentation analysis of Generic Drugs Market of Americas, APAC, EMEA region.
Further, the Generic Drugs Market report states that one challenge that can have restrict market growth is the threat of counterfeit drugs.
Key questions answered in Generic Drugs market report:
What will the Generic Drugs market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving Generic Drugs market? What are the challenges to Generic Drugs market growth? Who are the key vendors in Generic Drugs market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
